000 01487 a2200433 4500
005 20250511193654.0
264 0 _c19920626
008 199206s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(92)90640-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStephan, Z F
245 0 0 _aReduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid.
_h[electronic resource]
260 _bBiochemical pharmacology
_cMay 1992
300 _a1969-74 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnticholesteremic Agents
_xpharmacology
650 0 4 _aCardiovascular System
_xdrug effects
650 0 4 _aCell Nucleus
_xmetabolism
650 0 4 _aCholesterol
_xblood
650 0 4 _aCholic Acid
650 0 4 _aCholic Acids
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Thyroid Hormone
_xmetabolism
650 0 4 _aThyroxine
_xantagonists & inhibitors
650 0 4 _aTriiodothyronine
_xpharmacology
700 1 _aYurachek, E C
700 1 _aSharif, R
700 1 _aWasvary, J M
700 1 _aSteele, R E
700 1 _aHowes, C
773 0 _tBiochemical pharmacology
_gvol. 43
_gno. 9
_gp. 1969-74
856 4 0 _uhttps://doi.org/10.1016/0006-2952(92)90640-5
_zAvailable from publisher's website
999 _c1602768
_d1602768